Cannabis Use, Polysubstance Use, and Psychosis Spectrum Symptoms in a Community-Based Sample of US Youth

被引:28
作者
Jones, Jason D. [1 ]
Calkins, Monica E. [1 ]
Scott, J. Cobb [1 ,2 ]
Bach, Emily C. [1 ]
Gur, Raquel E. [1 ]
机构
[1] Univ Penn, Dept Psychiat, Perelman Sch Med, Neuropsychiat Sect, 3400 Spruce St,10th Floor,Gates Bldg, Philadelphia, PA 19104 USA
[2] Philadelphia VA Med Ctr, VISN Mental Illness Res Educ & Clin Ctr 4, Philadelphia, PA USA
关键词
Cannabis; Marijuana; Polysubstance; Psychosis; Schizophrenia; Philadelphia Neurodevelopmental Cohort; SUBSTANCE USE; MARIJUANA USE; METAANALYSIS; OUTCOMES; TOBACCO; RISK; SCHIZOPHRENIA; ADOLESCENCE; EXPERIENCES; PREVALENCE;
D O I
10.1016/j.jadohealth.2017.01.006
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Purpose: To examine how cannabis use and polysubstance use among cannabis users relate to psychosis spectrum (PS) symptoms in a large community-based sample of U.S. youth. Methods: Four thousand one hundred seventy-one youths (aged 14-21 years; mean = 16.90 years, SD = 1.85; 55% female) from the Philadelphia Neurodevelopmental Cohort completed assessments of substance use, PS symptoms, and confounding variables (e.g., demographics, comorbid psychopathology, and trauma exposure). Results: After adjusting for confounds, cannabis use by itself was not associated with increased odds of being classified as "psychosis spectrum."However, cannabis use in combination with tobacco or other substance use was associated with increased odds of PS classification (adjusted odds ratios [ORs] = 1.37e1.76). Follow-up symptom-level analyses revealed that cannabis use in combination with other substances was associated with subclinical positive symptoms (ORs = 1.95 and 2.24) and frequent cannabis use was associated with subclinical negative/disorganized symptoms (OR = 2.14). However, these symptom-level findings were reduced to trends after correction for multiple comparisons. Neither cannabis use nor polysubstance use was associated with threshold delusions or hallucinations. Conclusions: After adjusting for important confounds, there was minimal evidence for associations between cannabis use by itself and PS symptoms. More compelling evidence emerged for associations between polysubstance use among cannabis users and PS symptoms. This study highlights the importance of considering polysubstance use and confounds when examining associations between cannabis use and PS symptoms. Further longitudinal research is necessary to determine whether these findings represent causal associations or shared genetic and/or environmental vulnerability for substance use and PS symptoms. (C) 2017 Society for Adolescent Health and Medicine. All rights reserved.
引用
收藏
页码:653 / 659
页数:7
相关论文
共 40 条
[1]   Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study [J].
Arseneault, L ;
Cannon, M ;
Poulton, R ;
Murray, R ;
Caspi, A ;
Moffitt, TE .
BRITISH MEDICAL JOURNAL, 2002, 325 (7374) :1212-1213
[2]   Substance Use in Adolescence and Psychosis: Clarifying the Relationship [J].
Barkus, Emma ;
Murray, Robin M. .
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 6, 2010, 6 :365-389
[3]   Concurrent and Sustained Cumulative Effects of Adolescent Marijuana Use on Subclinical Psychotic Symptoms [J].
Bechtold, Jordan ;
Hipwell, Alison ;
Lewis, David A. ;
Loeber, Rolf ;
Pardini, Dustin .
AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (08) :781-789
[4]   Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men [J].
Bechtold, Jordan ;
Simpson, Theresa ;
White, Helene R. ;
Pardini, Dustin .
PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 2015, 29 (03) :552-563
[5]   The Philadelphia Neurodevelopmental Cohort: constructing a deep phenotyping collaborative [J].
Calkins, Monica E. ;
Merikangas, Kathleen R. ;
Moore, Tyler M. ;
Burstein, Marcy ;
Behr, Meckenzie A. ;
Satterthwaite, Theodore D. ;
Ruparel, Kosha ;
Wolf, Daniel H. ;
Roalf, David R. ;
Mentch, Frank D. ;
Qiu, Haijun ;
Chiavacci, Rosetta ;
Connolly, John J. ;
Sleiman, Patrick M. A. ;
Gur, Ruben C. ;
Hakonarson, Hakon ;
Gur, Raquel E. .
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2015, 56 (12) :1356-1369
[6]   The psychosis spectrum in a young US community sample: findings from the Philadelphia Neurodevelopmental Cohort [J].
Calkins, Monica E. ;
Moore, Tyler M. ;
Merikangas, Kathleen R. ;
Burstein, Marcy ;
Satterthwaite, Theodore D. ;
Bilker, Warren B. ;
Ruparel, Kosha ;
Chiavacci, Rosetta ;
Wolf, Daniel H. ;
Mentch, Frank ;
Qiu, Haijun ;
Connolly, John J. ;
Sleiman, Patrick A. ;
Hakonarson, Hakon ;
Gur, Ruben C. ;
Gur, Raquel E. .
WORLD PSYCHIATRY, 2014, 13 (03) :296-305
[7]   The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis [J].
D'Souza, DC ;
Perry, E ;
MacDougall, L ;
Ammerman, Y ;
Cooper, T ;
Wu, YT ;
Braley, G ;
Gueorguieva, R ;
Krystal, JH .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (08) :1558-1572
[8]   Genetic and environmental contributions to the diversity of substances used in adolescent twins: a longitudinal study of age and sex effects [J].
Derringer, Jaime ;
Krueger, Robert F. ;
McGue, Matt ;
Lacono, William G. .
ADDICTION, 2008, 103 (10) :1744-1751
[9]   Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study [J].
Di Forti, Marta ;
Marconi, Arianna ;
Carra, Elena ;
Fraietta, Sara ;
Trotta, Antonella ;
Bonomo, Matteo ;
Bianconi, Francesca ;
Gardner-Sood, Poonam ;
O'Connor, Jennifer ;
Russo, Manuela ;
Stilo, Simona A. ;
Marques, Tiago Reis ;
Mondelli, Valeria ;
Dazzan, Paola ;
Pariante, Carmine ;
David, Anthony S. ;
Gaughran, Fiona ;
Atakan, Zerrin ;
Iyegbe, Conrad ;
Powell, John ;
Morgan, Craig ;
Lynskey, Michael ;
Murray, Robin M. .
LANCET PSYCHIATRY, 2015, 2 (03) :233-238
[10]  
Fergusson DM, 2005, ADDICTION, V100, P354, DOI 10.1111/j.1360-0443.2005.01001.x